TY  - JOUR
T1  - New statins also produce fatigue: Spontaneous reporting as a complementary system to increase safety knowledge—reply
AU  - Golomb BA, Koperski S
Y1  - 2013/02/11
N1  - 10.1001/jamainternmed.2013.2113
JO  - JAMA Internal Medicine
SP  - 247
EP  - 248
VL  - 173
IS  - 3
N2  - 
We concur with Tarapués and colleagues. An analysis we conducted of patient reports of muscle problems (including fatigue)1 is in agreement with their Spanish data, extending fatigue adverse effects (AEs) to all statins. These data suggest that risk approximately parallels statin potency, as does our recent analysis of the US Food and Drug Administration AE reports focused on muscle-related AEs,2 although this latter analysis did not expressly address fatigue.

SN  - 2168-6106
M3  - doi: 10.1001/jamainternmed.2013.2113
UR  - http://dx.doi.org/10.1001/jamainternmed.2013.2113
ER  -